MEDIMMUNE LLC

MedImmune LLC specializes in the manufacturing of biological products and advanced biotechnology research, with a focused expertise in the development, stabilization, and storage of live attenuated vaccine seed lots for public health preparedness. Their technical capabilities encompass end-to-end biological product lifecycle management, including master and working seed lot characterization, stability testing under controlled environmental conditions, and strict adherence to regulatory protocols for biologics manufacturing. The contractor demonstrates deep proficiency in Good Manufacturing Practices (GMP), cold chain integrity, and compliance with FDA and HHS guidelines for biologic storage and release. Their work in research and development supports the advancement of next-generation vaccine platforms, particularly in the context of infectious disease response and emergency preparedness. The contractor maintains a consistent and long-standing relationship with the Department of Health and Human Services, primarily supporting programs under the Assistant Secretary for Preparedness and Response (ASPR). Their engagements involve critical public health infrastructure tasks such as contract closeout, deobligation of funds, and compliance with Federal Acquisition Regulation (FAR) 4.804, indicating a mature, audit-ready operational framework aligned with federal biodefense and pandemic response initiatives. MedImmune LLC operates primarily under NAICS 325414, which encompasses the manufacturing of non-diagnostic biological products, including vaccines and therapeutics derived from living organisms. Their market positioning is firmly rooted in the federal biodefense and biomanufacturing sector, serving as a specialized contractor for high-containment, precision-driven biological production and research. Their work supports national security and public health missions through scientifically rigorous, regulated manufacturing processes. As a 2L entity based in Gaithersburg, Maryland, MedImmune LLC is strategically located within the nation’s biopharmaceutical corridor. While no formal government certifications are listed, their consistent performance on HHS contracts reflects a proven track record in meeting stringent federal quality and compliance standards for biological product systems.